Newbury Pharmaceuticals AB Balance Sheet
Newbury Pharmaceuticals AB's total assets for Q2 2025 were kr87.67M, a decrease of -0.98% from the previous quarter. SE:NEWBRY total liabilities were kr42.89M for the fiscal quarter, a 2.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.